Podcast
Questions and Answers
What is the formal term for dementia as defined by the DSM-5?
What is the formal term for dementia as defined by the DSM-5?
- Neuropsychiatric Disturbance Syndrome (NDS)
- Major Neurocognitive Disorder (MND) (correct)
- Geriatric Cognitive Impairment (GCI)
- Behavioral and Psychological Symptoms of Dementia (BPSD)
Which of the following is NOT a typical etiology that leads to dementia?
Which of the following is NOT a typical etiology that leads to dementia?
- Vascular dementia
- Multiple sclerosis (correct)
- Lewy body dementia
- Alzheimer's disease
Behavioral and psychological symptoms of dementia (BPSD) primarily affect which two areas of a patient's life?
Behavioral and psychological symptoms of dementia (BPSD) primarily affect which two areas of a patient's life?
- Nutritional intake and sleep patterns
- Cardiovascular health and respiratory function
- Cognitive function and motor skills
- Functional abilities and quality of life (correct)
Which of the following best describes the nature of BPSD symptoms in relation to psychiatric disorders?
Which of the following best describes the nature of BPSD symptoms in relation to psychiatric disorders?
A patient with dementia exhibits sudden, intense fear and believes their caregiver is trying to harm them. Which BPSD symptom is most likely being displayed?
A patient with dementia exhibits sudden, intense fear and believes their caregiver is trying to harm them. Which BPSD symptom is most likely being displayed?
Apathy is a common BPSD symptom. Which of the following behaviors would MOST clearly indicate apathy in a dementia patient?
Apathy is a common BPSD symptom. Which of the following behaviors would MOST clearly indicate apathy in a dementia patient?
A clinician is developing a management plan for a dementia patient exhibiting BPSD. What is the MOST critical initial step?
A clinician is developing a management plan for a dementia patient exhibiting BPSD. What is the MOST critical initial step?
An interprofessional team is caring for a patient with dementia and severe agitation. Despite non-pharmacological interventions, the patient's agitation escalates, posing a safety risk. Which factor should the team prioritize when deciding whether to initiate pharmacological treatment for BPSD?
An interprofessional team is caring for a patient with dementia and severe agitation. Despite non-pharmacological interventions, the patient's agitation escalates, posing a safety risk. Which factor should the team prioritize when deciding whether to initiate pharmacological treatment for BPSD?
Which class of medications, when withdrawn, is least likely to contribute to Behavioral and Psychological Symptoms of Dementia (BPSD)?
Which class of medications, when withdrawn, is least likely to contribute to Behavioral and Psychological Symptoms of Dementia (BPSD)?
Akathisia, a potential cause of Behavioral and Psychological Symptoms of Dementia (BPSD), can arise from the use of which type of medication?
Akathisia, a potential cause of Behavioral and Psychological Symptoms of Dementia (BPSD), can arise from the use of which type of medication?
What percentage range of dementia patients are estimated to experience pain, which is associated with increased Behavioral and Psychological Symptoms of Dementia (BPSD)?
What percentage range of dementia patients are estimated to experience pain, which is associated with increased Behavioral and Psychological Symptoms of Dementia (BPSD)?
Which of the following is NOT a recommended approach for assessing comfort in patients with dementia?
Which of the following is NOT a recommended approach for assessing comfort in patients with dementia?
Which of the following tools is specifically designed and validated for objectively evaluating and tracking pain in advanced dementia?
Which of the following tools is specifically designed and validated for objectively evaluating and tracking pain in advanced dementia?
Why is establishing a clear baseline critically important when assessing Behavioral and Psychological Symptoms of Dementia (BPSD)?
Why is establishing a clear baseline critically important when assessing Behavioral and Psychological Symptoms of Dementia (BPSD)?
Which domain is NOT evaluated by the Neuropsychiatric Inventory (NPI) for assessing overall Behavioral and Psychological Symptoms of Dementia (BPSD)?
Which domain is NOT evaluated by the Neuropsychiatric Inventory (NPI) for assessing overall Behavioral and Psychological Symptoms of Dementia (BPSD)?
A patient with dementia exhibits increased agitation and aggression. Initial assessment reveals the patient is on a stable dose of a second-generation antipsychotic. Despite the stable dose, symptoms worsen. Considering the information provided, what is the MOST critical next step?
A patient with dementia exhibits increased agitation and aggression. Initial assessment reveals the patient is on a stable dose of a second-generation antipsychotic. Despite the stable dose, symptoms worsen. Considering the information provided, what is the MOST critical next step?
Which of the following non-pharmacological interventions has demonstrated anecdotal effectiveness in managing agitation?
Which of the following non-pharmacological interventions has demonstrated anecdotal effectiveness in managing agitation?
What is a significant limitation associated with the use of psychotropic medications in treating BPSD?
What is a significant limitation associated with the use of psychotropic medications in treating BPSD?
What percentage range of dementia patients receive analgesics for painful conditions, compared to those without dementia?
What percentage range of dementia patients receive analgesics for painful conditions, compared to those without dementia?
In the context of BPSD treatment, why is the empiric treatment of pain considered a crucial first step?
In the context of BPSD treatment, why is the empiric treatment of pain considered a crucial first step?
What was the primary outcome measure used in the multicenter cluster randomized controlled trial that examined the effect of a stepwise protocol for empiric treatment of pain in patients with dementia-related agitation?
What was the primary outcome measure used in the multicenter cluster randomized controlled trial that examined the effect of a stepwise protocol for empiric treatment of pain in patients with dementia-related agitation?
In the 8-week multicenter study on empiric pain treatment for BPSD, what was the magnitude of agitation reduction in the intervention group, and how does this compare to the effect seen with risperidone?
In the 8-week multicenter study on empiric pain treatment for BPSD, what was the magnitude of agitation reduction in the intervention group, and how does this compare to the effect seen with risperidone?
A clinician is deciding on a treatment plan for a patient with BPSD who exhibits wandering and repetitive vocalizations. Based on current evidence, which approach is MOST appropriate?
A clinician is deciding on a treatment plan for a patient with BPSD who exhibits wandering and repetitive vocalizations. Based on current evidence, which approach is MOST appropriate?
An elderly patient with dementia is prescribed pregabalin as part of a stepwise protocol for empiric pain management. Which of the following dosages of pregabalin would be LEAST appropriate, considering the study's findings and typical geriatric considerations for medication management?
An elderly patient with dementia is prescribed pregabalin as part of a stepwise protocol for empiric pain management. Which of the following dosages of pregabalin would be LEAST appropriate, considering the study's findings and typical geriatric considerations for medication management?
What is the recommended first-line pharmacotherapy for agitated behaviors in patients without Lewy body dementia or Parkinson's disease, after non-pharmacological interventions have been tried?
What is the recommended first-line pharmacotherapy for agitated behaviors in patients without Lewy body dementia or Parkinson's disease, after non-pharmacological interventions have been tried?
In patients with Lewy body dementia or Parkinson's disease experiencing agitation, what is the recommended next step if Citalopram or Sertraline are ineffective?
In patients with Lewy body dementia or Parkinson's disease experiencing agitation, what is the recommended next step if Citalopram or Sertraline are ineffective?
How often should trials of antipsychotic tapering be attempted?
How often should trials of antipsychotic tapering be attempted?
Why should Olanzapine generally be avoided when cross-titrating antipsychotics?
Why should Olanzapine generally be avoided when cross-titrating antipsychotics?
For depression in patients with dementia, what medication is suggested to be added if there is a limited response after an adequate trial of Citalopram or Sertraline?
For depression in patients with dementia, what medication is suggested to be added if there is a limited response after an adequate trial of Citalopram or Sertraline?
Which neurostimulation therapy has shown benefit in most studies for treatment-refractory patients with dementia?
Which neurostimulation therapy has shown benefit in most studies for treatment-refractory patients with dementia?
A patient with Parkinson's disease exhibits agitation. They are already prescribed an acetylcholinesterase inhibitor. Which of the following would be the MOST appropriate next step according to the guidelines?
A patient with Parkinson's disease exhibits agitation. They are already prescribed an acetylcholinesterase inhibitor. Which of the following would be the MOST appropriate next step according to the guidelines?
A patient with severe agitation and aggressive symptoms requires immediate initiation of antipsychotic therapy. Which crucial step should NOT be overlooked despite the initiation of pharmacotherapy?
A patient with severe agitation and aggressive symptoms requires immediate initiation of antipsychotic therapy. Which crucial step should NOT be overlooked despite the initiation of pharmacotherapy?
Which of the following best describes the focus of the Cohen-Mansfield Agitation Inventory (CMAI)?
Which of the following best describes the focus of the Cohen-Mansfield Agitation Inventory (CMAI)?
What is the initial step recommended for managing Behavioral and Psychological Symptoms of Dementia (BPSD), assuming the patient does not pose an immediate danger to themselves or others?
What is the initial step recommended for managing Behavioral and Psychological Symptoms of Dementia (BPSD), assuming the patient does not pose an immediate danger to themselves or others?
For assessing Behavioral and Psychological Symptoms of Dementia (BPSD), what is considered the most accurate method to gather information from caregivers regarding a patient's symptoms?
For assessing Behavioral and Psychological Symptoms of Dementia (BPSD), what is considered the most accurate method to gather information from caregivers regarding a patient's symptoms?
A patient with dementia is exhibiting aggression and poses a risk of injury to caregivers. Pharmacological interventions have been attempted but have been unsuccessful. Which of the following is the MOST appropriate setting for managing this patient?
A patient with dementia is exhibiting aggression and poses a risk of injury to caregivers. Pharmacological interventions have been attempted but have been unsuccessful. Which of the following is the MOST appropriate setting for managing this patient?
Which of the following scenarios necessitates managing a patient with BPSD in a hospital setting?
Which of the following scenarios necessitates managing a patient with BPSD in a hospital setting?
A caregiver reports that a patient with dementia frequently resists assistance during dressing, exhibiting distress about 60% of the time, which causes the caregiver significant upset (rated 8 out of 10 on a distress scale). According to the provided information, what is the next recommended step in managing this BPSD?
A caregiver reports that a patient with dementia frequently resists assistance during dressing, exhibiting distress about 60% of the time, which causes the caregiver significant upset (rated 8 out of 10 on a distress scale). According to the provided information, what is the next recommended step in managing this BPSD?
What is the PRIMARY reason systematic trials of evidence-based pharmacological therapies are considered in the management of BPSD?
What is the PRIMARY reason systematic trials of evidence-based pharmacological therapies are considered in the management of BPSD?
A researcher aims to comprehensively evaluate the effectiveness of a novel intervention for managing agitation in patients with Alzheimer's disease. Considering the potential differences captured by various assessment tools, which combination of assessments would offer the MOST thorough and nuanced understanding of the intervention's impact on agitation and related BPSD?
A researcher aims to comprehensively evaluate the effectiveness of a novel intervention for managing agitation in patients with Alzheimer's disease. Considering the potential differences captured by various assessment tools, which combination of assessments would offer the MOST thorough and nuanced understanding of the intervention's impact on agitation and related BPSD?
Which of the following antipsychotics is generally LEAST preferred in Lewy body dementia and dementia associated with Parkinson's disease due to the risk of worsening motor symptoms?
Which of the following antipsychotics is generally LEAST preferred in Lewy body dementia and dementia associated with Parkinson's disease due to the risk of worsening motor symptoms?
What special consideration is required when prescribing clozapine?
What special consideration is required when prescribing clozapine?
What is the established starting and target dosage of pimavanserin for psychosis related to Parkinson's disease?
What is the established starting and target dosage of pimavanserin for psychosis related to Parkinson's disease?
Patients on antipsychotics should be monitored for adverse motor effects and medication tapering should be attempted how often?
Patients on antipsychotics should be monitored for adverse motor effects and medication tapering should be attempted how often?
According to cited research, what is the approximate percentage of patients on long-term antipsychotics who can be successfully discontinued without a worsening of BPSD?
According to cited research, what is the approximate percentage of patients on long-term antipsychotics who can be successfully discontinued without a worsening of BPSD?
Which of the following SSRIs has demonstrated effectiveness in improving agitation and aggression in patients, according to a 2011 meta-analysis:
Which of the following SSRIs has demonstrated effectiveness in improving agitation and aggression in patients, according to a 2011 meta-analysis:
In a study of Citalopram at 30 mg daily versus placebo, what average increase in corrected QT interval was observed in patients?
In a study of Citalopram at 30 mg daily versus placebo, what average increase in corrected QT interval was observed in patients?
When initiating SSRIs for mild to moderate BPSD in elderly patients, what critical principle from geropsychiatry should guide the dosing strategy?
When initiating SSRIs for mild to moderate BPSD in elderly patients, what critical principle from geropsychiatry should guide the dosing strategy?
Flashcards
Major Neurocognitive Disorder (MND)
Major Neurocognitive Disorder (MND)
A formal term for dementia, defined by the DSM-5, involving cognitive decline and loss of function.
Behavioral and Psychological Symptoms of Dementia (BPSD)
Behavioral and Psychological Symptoms of Dementia (BPSD)
Neuropsychiatric symptoms like delusions, apathy, anxiety, or disinhibition that accompany dementia.
Common Etiologies of Dementia
Common Etiologies of Dementia
Includes Alzheimer's, vascular, frontotemporal, Lewy body, and Parkinson's disease.
Characteristics of BPSD symptoms
Characteristics of BPSD symptoms
Signup and view all the flashcards
Settings where BPSD May Present
Settings where BPSD May Present
Signup and view all the flashcards
BPSD Treatment Approaches
BPSD Treatment Approaches
Signup and view all the flashcards
Impact of BPSD symptoms
Impact of BPSD symptoms
Signup and view all the flashcards
How is Dementia Diagnosed?
How is Dementia Diagnosed?
Signup and view all the flashcards
Medications causing BPSD
Medications causing BPSD
Signup and view all the flashcards
Medication withdrawal & BPSD
Medication withdrawal & BPSD
Signup and view all the flashcards
Akathisia & BPSD
Akathisia & BPSD
Signup and view all the flashcards
Physical discomfort & BPSD
Physical discomfort & BPSD
Signup and view all the flashcards
Pain & BPSD
Pain & BPSD
Signup and view all the flashcards
PAINAD/FLACC scales
PAINAD/FLACC scales
Signup and view all the flashcards
Relevant Psychiatric History
Relevant Psychiatric History
Signup and view all the flashcards
NPI and BEHAVE-AD
NPI and BEHAVE-AD
Signup and view all the flashcards
BPSD Assessment
BPSD Assessment
Signup and view all the flashcards
BEHAVE-AD Domains
BEHAVE-AD Domains
Signup and view all the flashcards
CMAI Categories
CMAI Categories
Signup and view all the flashcards
Practical BPSD Assessment
Practical BPSD Assessment
Signup and view all the flashcards
Daily Diary
Daily Diary
Signup and view all the flashcards
BPSD Intervention
BPSD Intervention
Signup and view all the flashcards
Delirium Setting
Delirium Setting
Signup and view all the flashcards
Geropsychiatry Unit Criteria
Geropsychiatry Unit Criteria
Signup and view all the flashcards
Simple Tasks for Agitation
Simple Tasks for Agitation
Signup and view all the flashcards
Busy Quilts
Busy Quilts
Signup and view all the flashcards
Weighted Blankets
Weighted Blankets
Signup and view all the flashcards
Psychotropic Medications for BPSD
Psychotropic Medications for BPSD
Signup and view all the flashcards
Treating Wandering and Vocalizations
Treating Wandering and Vocalizations
Signup and view all the flashcards
Empiric Treatment of Pain
Empiric Treatment of Pain
Signup and view all the flashcards
Stepwise Protocol for Pain Treatment
Stepwise Protocol for Pain Treatment
Signup and view all the flashcards
Pain Relief and Agitation
Pain Relief and Agitation
Signup and view all the flashcards
Antipsychotic use in Lewy body and Parkinson's Dementia
Antipsychotic use in Lewy body and Parkinson's Dementia
Signup and view all the flashcards
Clozapine: Monitoring
Clozapine: Monitoring
Signup and view all the flashcards
Pimavanserin (Nuplazid)
Pimavanserin (Nuplazid)
Signup and view all the flashcards
Pimavanserin Dosage
Pimavanserin Dosage
Signup and view all the flashcards
Antipsychotics: Risks
Antipsychotics: Risks
Signup and view all the flashcards
Antipsychotic Medication Monitoring
Antipsychotic Medication Monitoring
Signup and view all the flashcards
SSRIs for Agitation/Aggression
SSRIs for Agitation/Aggression
Signup and view all the flashcards
SSRI Dosing in BPSD
SSRI Dosing in BPSD
Signup and view all the flashcards
Ineffective Intervention
Ineffective Intervention
Signup and view all the flashcards
First-Line for Agitation
First-Line for Agitation
Signup and view all the flashcards
Risperidone or Aripiprazole
Risperidone or Aripiprazole
Signup and view all the flashcards
Agitation in LBD/PD
Agitation in LBD/PD
Signup and view all the flashcards
Antipsychotic Tapering
Antipsychotic Tapering
Signup and view all the flashcards
Switching Antipsychotics
Switching Antipsychotics
Signup and view all the flashcards
Depression Treatment
Depression Treatment
Signup and view all the flashcards
Refractory Treatment Options
Refractory Treatment Options
Signup and view all the flashcards
Study Notes
- Dementia is a term for major neurocognitive disorder, diagnosed by cognitive decline and impaired daily function, as defined by the DSM-5.
- Etiologies of dementia include Alzheimer's, vascular, frontotemporal, Lewy body, and Parkinson's diseases.
- Behavioral and psychological symptoms of dementia (BPSD) involve neuropsychiatric disturbances impacting the management and prognosis of dementia. Non-pharmacological and pharmacological interventions can improve symptoms.
- BPSD includes emotional, perceptual, and behavioral disturbances which can be classified into cognitive/perceptual, motor, verbal, emotional, and vegetative domains.
Etiology of BPSD
- BPSD arises from interactions between biology, prior experiences, and the environment.
- Agitation, disinhibition, and psychosis in dementia are linked to reduced volume and metabolism in brain areas regulating emotion, self-awareness, and perception.
- Neurotransmission imbalances of cholinergic, noradrenergic, dopaminergic, serotonergic, and glutamatergic systems are correlated with BPSD.
- Non-biological factors contributing to BPSD are neuroticism, pre-morbid PTSD, poor caregiver communication, and sensory over or under stimulation.
- Environmental factors could also include unmet needs, learning or behavior factors, and an environment that doesn't match a caregiver's capabilities.
Epidemiology
- In 2016, dementia affected approximately 43.8 million people globally, a 117% increase from 1990, making it the world's fifth leading cause of mortality
- Up to 97% of community-dwelling dementia patients will experience BPSD, with symptom severity increasing over time and correlating with institutional placement
- Delusions are common in Alzheimer's, depression and apathy in vascular dementia, and disinhibition/eating disturbances in frontotemporal dementia.
History and Physical Examination
- Goal of history intake for BPSD is to establish priorities, characterize symptoms, and identify reversible exacerbating factors
- Physical exam confirms historical data and identifies alternative contributing conditions
- "Sundowning," where behavioral disturbances worsen in the evening, affects up to two-thirds of dementia patients.
- Delusions are commonly paranoid, such as Capgras or Othello syndrome as well as agitation, aggression, wandering, apathy, disinhibition, and sleep disturbances.
- Physical exam focuses on identifying factors worsening BPSD, such as delirium or discomfort, assessing level of consciousness or signs of pain. Physical findings like fever, hypoxia, abdominal tenderness, fluid overload, inflammation, or neurologic deficits may indicate delirium.
Evaluation
- Acute or subacute onset of symptoms warrants basic studies such as CBC, electrolytes, liver/kidney function tests, urinalysis, thyroid function tests, toxicology screen, and head CT.
Prioritization
- Characterize the symptoms; patients endangering themselves or others may require hospitalization
- Assess safety: assess aggressive behaviors, property damage, and refusal of basic care.
- Identify delirium: determine the likely underlying medical cause, as treatment in an inpatient setting is likely required
Characterize the Symptoms
- Caregivers should describe what they see rather than using generic terms that different people might interpret differently.
- Determine onset, frequency, timing, duration, trajectory, and association with environmental/medication changes
Assess Comfort
- Because pain is present in 46% to 56% of patients with dementia, it is important to review the patient's medical history for painful conditions and ask caregivers about the patient's self-reported pain and any nonverbal signs.
- Assessment tools include the Pain Assessment in Advanced Dementia (PAINAD) or Face, Legs, Activity, Cry, Consolability (FLACC) scale.
Create a Baseline
- Clinicians can use a standarized instrument such as the Neuropsychiatric Inventory (NPI) or the Behavioral Pathology in Alzheimer Disease Rating Scale (BEHAVE-AD).
Treatment
- Treatment includes appropriate setting selection, treating discomfort, non-pharmacological interventions, and systematic pharmacological trials
Non-Pharmacological Interventions
- Useful for mild BPSD
- Includes caregiver training, environmental modifications, and activity adaptations
- Alzheimer Association can provide modules and in-person training classes
Pharmacological Interventions
- Psychotropic medications may be used to treat BPSD, but side effects may outweigh benefits
- Empiric treatment of pain: Patients can be started on 3g of acetaminophen daily for pain relief
- Antipsychotics: Risperidone, Olanzapine, Quetiapine and Aripiprazole and can be used to treat agitation and aggression
Differential Diagnosis
- Delirium demonstrates acute onset, fluctuating course, and the presence of an underlying medical condition, medication or psychoactive substance, or medication withdrawal
- Presentations of psychiatric conditions, such as schizophrenia, bipolar disorder, major depressive disorder, and post-traumatic stress disorder, may be quite similar to BPSD
Prognosis
- BPSD correlates with more rapid progression of dementia and earlier mortality; whether the treatment has any impact on these variables is unknown
Complications
- Predict more rapid cognitive decline and earlier mortality
- Associated with increased hospital length of stay, hospital complications, earlier nursing home placement, and increased rates of psychiatric and cardiovascular disorders in family caregivers
Enhancing Healthcare Team Outcomes
- Effective management of BPSD requires a coordinated interprofessional healthcare team that partners with the patient's home caregiver
- Each member of the healthcare team has varying expertise and are responsible for maintaining clear communication, informing everyone regarding any concerns or new developments, and addressing safety risks.
Deterrence and Patient Education
- Strategies that have been shown to reduce the risk of cognitive decline and the development of dementia, include Both a dietary intervention combining a Mediterranean Diet with the Dietary Approach to Systolic Hypertension (DASH) and pharmacological treatment for hypertension
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Explore dementia's formal definition, typical etiologies and impact. Understand Behavioral and Psychological Symptoms of Dementia (BPSD), focusing on symptoms like apathy and fear. Learn critical steps for managing BPSD, prioritizing safety and interprofessional collaboration.